Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Cytosorbents (CTSO) Shares Issued (2016 - 2025)

Cytosorbents' Shares Issued history spans 14 years, with the latest figure at -$4.0 million for Q4 2025.

  • Quarterly results put Shares Issued at -$4.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.4 million (changed N/A YoY), and the annual figure for FY2025 was $1.4 million, changed.
  • Shares Issued for Q4 2025 was -$4.0 million at Cytosorbents, down from -$306.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $5.4 million in Q1 2025 to a low of -$4.0 million in Q4 2025.
  • The 4-year median for Shares Issued is $42550.0 (2023), against an average of $193498.2.
  • The sharpest move saw Shares Issued crashed 100.15% in 2024, then surged 10028.68% in 2025.
  • Year by year, Shares Issued stood at $9076.0 in 2021, then crashed by 45.23% to $4971.0 in 2023, then crashed by 104.79% to -$238.0 in 2024, then tumbled by 1660824.37% to -$4.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$4.0 million, -$306.0, and $5.4 million for Q4 2025, Q2 2025, and Q1 2025 respectively.